Ethical analysis of the justifiability of labelling with COPD for smoking cessation
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function
- Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey
- Polymorphisms in the β2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers
- The overlap syndrome of asthma and COPD: what are its features and how important is it?
- Smokers with airway obstruction are more likely to quit smoking
- Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
- Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men
- Persistence of circulating endothelial microparticles in COPD despite smoking cessation
- Gender differences in COPD: are women more susceptible to smoking effects than men?
- Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample